NOVARTIS AG (NVSEF)
Clinical trial NCT06846281 updates: 1. completion date: 2031-06-24 → 2031-06-25 2. primary completion date: 2029-07-24 → 2029-07-25 3. enrollment: 360 → 400 participants
Clinical trial NCT06846281 updates: 1. completion date: 2031-06-24 → 2031-06-25 2. primary completion date: 2029-07-24 → 2029-07-25 3. enrollment: 360 → 400 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical